Shop, Drag & Drop to the Rescue of the Last Minute Shoppers

NEW YORK, NY (ContentDesk) December 14, 2005 -- Wall Street based shopping search engine Sortprice.com is here to the rescue of all last minute shoppers who could not find the time or did not want to deal with the crowds of their local mall. With the holiday season almost at a close, shoppers can now finally get their gifts without worrying about not being able to find that special and hard to find present.With Sortprice.coms unique Shop, Drag & Drop' function, grandchildren and adults alike can create their own special holiday gift list, compare prices side by side and perhaps more importantly, email the list to those shoppers who never seem to give the right present. This unique option allows consumers to shop for digital cameras, remote control cars and even that new stroller for the new baby on the way  all at the lowest prices and with the easy to use drag and drop feature. Even the most web-phobic of shoppers can manipulate this feature. No more receiving that pair of socks or the same sweater you received last year  Sortprice.com is out to save the day and your holiday shopping.

????
Sortprice.com is an advanced shopping search engine designed to facilitate the online shopping experience with a user-friendly interface that allows consumers to search for products and compare prices. Sortprice.com provides free product listings and accepts any data-feed format from internet retailers. Sortprice.com is dedicated to maintaining and expanding a simple-to-use, time and cost-effective environment for the consumers and merchants alike. For more information, visit www.sortprice.com. Here are some recent hot searches on SortPrice.com:Digital Cameras http://www.sortprice.com/search-C-Digital_CamerasCanon PowerShot SD400http://www.sortprice.com/search-CSp-Digital_cameras-Canon_PowerShot_SD400Plasma TVshttp://www.sortprice.com/search-C-Plasma_TVsUgg Boots http://www.sortprice.com/search?action=Search&String=Ugg+BootsPanini Maker http://www.sortprice.com/search?action=Search&String=Panini+Maker&SearchWithin=MP3 Player http://www.sortprice.com/search-CSp-Mp3_players-mp3_playerCompare products and prices with Shop, Drag & Drophttp://www.sortprice.com/compare.htmlLisa AkermanMedia Relationswww.SortPrice.comThe Advanced Shopping Search EngineLakerman @ sortprice.com(212) 461-220444 Wall Street 12th floorNew York, NY 10005.



New Tinted-Glass LCD Monitors Combine Eye Protection and Exquisite Design

Seoul, South Korea (ContentDesk) July 27, 2004 -- Prestigio, one of the most dynamic international manufacturers of LCD displays and TV's, mobile computers, and plasma TV's, has unveiled two new exquisite 15" and 17" LCD multimedia monitors P156 and P176, and began their distribution throughout Europe, Middle East and Africa. The new monitors feature tinted-glass screen coating that ensures a more accentuated image, better focus, and increased eye protection. Undeniably attractive, the use of glass serves several purposes. It enhances the physical appearance of the unit as well as the color intensity of the display. The specially conditioned solid glass protects the LCD panel from direct contact with the elements, thus reducing the likelihood of damage.

It's elegant styling is a welcome presence in any workplace, either at home or in the office.However, most importantly, the tinted-glass coating contributes to the prevention of the so-called Computer Vision Syndrome (CVS), with...

New Tinted-Glass LCD Monitors Combine Eye Protection and Exquisite Design
Plasma > New Tinted-Glass LCD Monitors Combine Eye Protection and Exquisite Design

New England Journal of Medicine Publishes Research by UAMS Team on Myeloma Treatment Using Thalidomide -- Drug Increases Remission Rates in Clinical Trial

Little Rock, AR (ContentDesk) March 9, 2006 -- A long-term study on the effectiveness of the drug thalidomide as part of the treatment for multiple myeloma, one of the least curable cancers, showed improved remission rates in patients, reported a team of Myeloma Institute for Research and Therapy (http://myeloma.uams.edu) researchers led by Bart Barlogie, M.D., Ph.D., in the latest issue of the New England Journal of Medicine.The article Thalidomide and Hematopoietic-Cell Transplantation for Multiple Myeloma (http://content.nejm.org/cgi/content/full/354/10/1021?ijkey=NpKKiGnrNpOIE&keytype=ref&siteid=nejm) showed results from the addition of thalidomide to a myeloma treatment regimen that included high-dose, melphalan-based chemotherapy in a setting of tandem peripheral blood stem-cell transplants. In the...

New England Journal of Medicine Publishes Research by UAMS Team on Myeloma Treatment Using Thalidomide -- Drug Increases Remission Rates in Clinical Trial
Plasma > New England Journal of Medicine Publishes Research by UAMS Team on Myeloma Treatment Using Thalidomide -- Drug Increases Remission Rates in Clinical Trial

Choosing a Plasma TV

You've finally made up your mind to buy a plasma TV.
You dream of watching your favorite television shows in full stereo, with sharp, crisp picture resolution.
But how do you go about finding your dream TV?
Here are a few tips that will help you get started.

The first thing that you should do is to decide on the size of the television monitor you want.
Generally speaking, plasma TVs begin at around 32" and go as large as 63".
The most common screen sizes are usually 32", 42", 50" and 61".

So, measure the area where you want to place your TV to get an idea of which size would be most practical for you.
It's important to remember that most plasma TVs have detachable speakers, so you will need to allow for a few extra inches on either side of where the screen will be.

You may well have the option to buy extra slim speakers, which attach directly to the monitor, if you don't want to use your own or...

Choosing a Plasma TV
Plasma > Choosing a Plasma TV

New England Journal of Medicine Publishes Research by UAMS Team on Myeloma Treatment Using Thalidomide -- Drug Increases Remission Rates in Clinical Trial

Little Rock, AR (ContentDesk) March 9, 2006 -- A long-term study on the effectiveness of the drug thalidomide as part of the treatment for multiple myeloma, one of the least curable cancers, showed improved remission rates in patients, reported a team of Myeloma Institute for Research and Therapy (http://myeloma.uams.edu) researchers led by Bart Barlogie, M.D., Ph.D., in the latest issue of the New England Journal of Medicine.The article Thalidomide and Hematopoietic-Cell Transplantation for Multiple Myeloma (http://content.nejm.org/cgi/content/full/354/10/1021?ijkey=NpKKiGnrNpOIE&keytype=ref&siteid=nejm) showed results from the addition of thalidomide to a myeloma treatment regimen that included high-dose, melphalan-based chemotherapy in a setting of tandem peripheral blood stem-cell transplants. In the...

New England Journal of Medicine Publishes Research by UAMS Team on Myeloma Treatment Using Thalidomide -- Drug Increases Remission Rates in Clinical Trial
Plasma > New England Journal of Medicine Publishes Research by UAMS Team on Myeloma Treatment Using Thalidomide -- Drug Increases Remission Rates in Clinical Trial

MKI Gains CE Mark and EU Approval for Four Key Cardiac Markers

Tokyo, Japan, (ContentDesk) January 13, 2006 -- Mitsubishi Kagaku Iatron, Inc.(MKI), a subsidiary of Mitsubishi Chemical Corporation announced
today that it has received marketing approval under the European Unions IVD directive for their Troponin I, creatinine kinase M/B, myoglobin and D-Dimer in-vitro diagnostic assays.
All four tests were approved to be performed on their PATHFAST" Point-Of-Care analyzer.
We are pleased with achieving this important milestone.
MKI is now positioned to further enhance its stance as a global leader in the diagnostic testing market, said Toshihiko Yoshitomi Ph.D., President, Mitsubishi Kagaku Iatron, Inc.
This is only the beginning in our mission to build a unique Point-Of-Care testing platform that will allow the clinician to rapidly test for critical disease states in a near patient setting.The PATHFAST" is a compact immunoanalyzer that utilizes patented, CLEIA-MAGTRATION technology.

All four...

MKI Gains CE Mark and EU Approval for Four Key Cardiac Markers
Plasma > MKI Gains CE Mark and EU Approval for Four Key Cardiac Markers

gift baskets Plasma gift baskets Plasma

gift baskets Plasma gift baskets Plasma

Plasma Plasma

eplasmaarticles.com, all rights reserved where applicable
Plasma
This page loaded in 0.03202 seconds.